S Radulovic
Overview
Explore the profile of S Radulovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
861
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brough H, Gourgey R, Radulovic S, Caubet J, Lack G, Anagnostou A
Curr Treat Options Allergy
. 2021 Jun;
8(2):97-110.
PMID: 34150446
Purpose Of Review: In this review, we sought to describe the most recent advances in the dietary and medical management of peanut and tree nut allergy, including selective introduction and...
2.
Jabbar-Lopez Z, Craven J, Logan K, Greenblatt D, Marrs T, Radulovic S, et al.
Br J Dermatol
. 2019 Oct;
183(2):285-293.
PMID: 31599965
Background: Several studies have identified an association between water hardness and atopic eczema (AE); however, there is a paucity of longitudinal data in early life. Objectives: To examine whether water...
3.
Arsenijevic T, Micev M, Nikolic V, Gavrilovic D, Radulovic S, Pesko P
J BUON
. 2013 Jan;
17(4):706-11.
PMID: 23335529
Purpose: To evaluate the expression of epidermal growth factor receptor (EGFR), p53, p21 and thymidylate synthase (TS) in a pretherapy biopsy specimen of locally advanced squamous cell esophageal cancer and...
4.
Milovic-Kovacevic M, Srdic-Rajic T, Radulovic S, Bjelogrlic S, Gavrilovic D
J BUON
. 2012 Feb;
16(4):708-14.
PMID: 22331726
Purpose: The purpose of this study was to investigate whether the expression of excision repair cross complementing 1 (ERCC1) protein I in tumor tissue was associated with resistance to standard...
5.
Malisic E, Jankovic R, Jakovljevic K, Radulovic S
J BUON
. 2012 Feb;
16(4):701-7.
PMID: 22331725
Purpose: Lack of symptoms in early stages of disease and resistance to chemotherapy make epithelial ovarian carcinomas one of the most lethal neoplasms among gynaecological malignancies. The aim of this...
6.
Radulovic S, Wilson D, Calderon M, Durham S
Allergy
. 2011 Mar;
66(6):740-52.
PMID: 21443635
Allergic rhinitis is common worldwide, with significant morbidity and impact on quality of life. In patients who don't respond adequately to anti-allergic drugs. Subcutaneous allergen immunotherapy is effective although requires...
7.
Flohr C, England K, Radulovic S, McLean W, Campbel L, Barker J, et al.
Br J Dermatol
. 2010 Dec;
163(6):1333-6.
PMID: 21137118
Background: Filaggrin loss-of-function (FLG) mutations are associated with eczema and skin barrier impairment, but it is unclear whether skin barrier impairment precedes phenotypic eczema in FLG mutation carriers. Objectives: To...
8.
Malisic E, Jankovic R, Slavkovic D, Milovic-Kovacevic M, Radulovic S
J BUON
. 2010 Apr;
15(1):101-6.
PMID: 20414935
Purpose: Ovarian cancer is the leading cause of death from gynecological malignancies. The early stages of this disease are asymptomatic and more than 75% of the cases are diagnosed with...
9.
Jankovic R, Radulovic S, Brankovic-Magic M
J BUON
. 2009 Sep;
14 Suppl 1:S43-9.
PMID: 19785069
In the process of RNA interference (RNAi), small RNAs pair with complementary messenger RNAs preventing their expression. The discovery of RNAi has revolutionized our understanding of gene regulation. Since cancer...
10.
Radulovic S, Brankovic-Magic M, Malisic E, Jankovic R, Dobricic J, Plesinac-Karapandzic V, et al.
J BUON
. 2009 Sep;
14 Suppl 1:S165-8.
PMID: 19785060
Producing effective therapeutic vaccines has proved much more difficult and challenging than developing cancer preventive vaccines. Despite huge research in the area of cancer immunology, FDA/EMEA have not approved any...